UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 92

Sortiert nach

RPA and Rad51 constitute a cell intrinsic mechanism to protect the cytosol from self DNA

Nature communications, 2016-05, Vol.7 (1), p.11752-11752, Article 11752

2016

Volltextzugriff (PDF)

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene

Nature genetics, 2010-05, Vol.42 (5), p.410-414

2010

Volltextzugriff (PDF)

Contralateral Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Journal of clinical oncology, 2009-12, Vol.27 (35), p.5887-5892

2009

Volltextzugriff (PDF)

Targeted capture-based NGS is superior to multiplex PCR-based NGS for hereditary BRCA1 and BRCA2 gene analysis in FFPE tumor samples

BMC cancer, 2019-04, Vol.19 (1), p.396-15, Article 396

2019

Volltextzugriff (PDF)

Analysis of 30 putative BRCA1 splicing mutations in hereditary breast and ovarian cancer families identifies exonic splice site mutations that escape in silico prediction

PloS one, 2012-12, Vol.7 (12), p.e50800-e50800

2012

Volltextzugriff (PDF)

Identification and Functional Testing of ERCC2 Mutations in a Multi-national Cohort of Patients with Familial Breast- and Ovarian Cancer

PLoS genetics, 2016-08, Vol.12 (8), p.e1006248-e1006248

2016

Volltextzugriff (PDF)

Breast cancer characteristics and surgery among women with Li‐Fraumeni syndrome in Germany—A retrospective cohort study

Cancer medicine (Malden, MA), 2021-11, Vol.10 (21), p.7747-7758

2021

Volltextzugriff (PDF)

Sarcoma of the Uterus. Guideline of the DGGG and OEGGG (S2k Level, AWMF Register Number 015/074, February 2019)

Geburtshilfe und Frauenheilkunde, 2019-10, Vol.79 (10), p.1043-1060

2019

Volltextzugriff (PDF)

Late onset Li-Fraumeni Syndrome with bilateral breast cancer and other malignancies: case report and review of the literature

BMC cancer, 2012-06, Vol.12 (1), p.217-217, Article 217

2012

Volltextzugriff (PDF)

Familiärer Brust- und Eierstockkrebs (einschließlich Hormone)

Gynäkologe (Berlin), 2020-11, Vol.53 (11), p.739-747

2020

Volltextzugriff (PDF)

Personalisierte Medizin bei soliden Tumoren

Medizinische Genetik, 2016-12, Vol.28 (4), p.443-451

2016

Volltextzugriff (PDF)

Germline truncating-mutations in BRCA1 and MSH6 in a patient with early onset endometrial cancer

BMC cancer, 2012-11, Vol.12 (1), p.531-531, Article 531

2012

Volltextzugriff (PDF)

Treatment in Certified Breast Cancer Centers Improves Chances of Survival of Patients with Breast Cancer: Evidence Based on Health Care Data from the WiZen Study

Geburtshilfe und Frauenheilkunde, 2024-02, Vol.84 (2), p.153-163

2024

Volltextzugriff (PDF)

Impact of breast cancer subtypes and patterns of metastasis on outcome

Breast cancer research and treatment, 2015-04, Vol.150 (3), p.621-629

2015

Volltextzugriff (PDF)

Changes in classification of genetic variants in BRCA1 and BRCA2

Archives of gynecology and obstetrics, 2018-02, Vol.297 (2), p.279-280

2018

Volltextzugriff (PDF)

Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D

JNCI : Journal of the National Cancer Institute, 2020-12, Vol.112 (12), p.1242-1250

2020

Volltextzugriff (PDF)

LIFESTYLE und erblicher Brustkrebs: Welche nicht-genetischen Faktoren beeinflussen das Erkrankungsrisiko?

Medizinische Genetik, 2015-08, Vol.27 (2), p.237-243

2015

Volltextzugriff (PDF)

LIFESTYLE und erblicher Brustkrebs

Medizinische Genetik, 2015-08, Vol.27 (2), p.237-243

2015

Volltextzugriff (PDF)

High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer

Breast cancer research and treatment, 2019-05, Vol.175 (1), p.217-228

2019

Volltextzugriff (PDF)

Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1)

PloS one, 2017-10, Vol.12 (10), p.e0186043-e0186043

2017

Volltextzugriff (PDF)

Familial Breast Cancer - Targeted Therapy in Secondary and Tertiary Prevention

Breast care (Basel, Switzerland), 2015-01, Vol.10 (1), p.27-31

2015

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(86)

Publikationsform

Artikel
(85)
Bücher
(6)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

RPA and Rad51 constitute a cell intrinsic mechanism to protect the cytosol from self DNA

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene

Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history

Contralateral Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Targeted capture-based NGS is superior to multiplex PCR-based NGS for hereditary BRCA1 and BRCA2 gene analysis in FFPE tumor samples

Pathological Response in the Breast and Axillary Lymph Nodes after Neoadjuvant Systemic Treatment in Patients with Initially Node-Positive Breast Cancer Correlates with Disease Free Survival: An Exploratory Analysis of the GeparOcto Trial

Analysis of 30 putative BRCA1 splicing mutations in hereditary breast and ovarian cancer families identifies exonic splice site mutations that escape in silico prediction

Identification and Functional Testing of ERCC2 Mutations in a Multi-national Cohort of Patients with Familial Breast- and Ovarian Cancer

Breast cancer characteristics and surgery among women with Li‐Fraumeni syndrome in Germany—A retrospective cohort study

Sarcoma of the Uterus. Guideline of the DGGG and OEGGG (S2k Level, AWMF Register Number 015/074, February 2019)

Late onset Li-Fraumeni Syndrome with bilateral breast cancer and other malignancies: case report and review of the literature

Familiärer Brust- und Eierstockkrebs (einschließlich Hormone)

Personalisierte Medizin bei soliden Tumoren

Germline truncating-mutations in BRCA1 and MSH6 in a patient with early onset endometrial cancer

Treatment in Certified Breast Cancer Centers Improves Chances of Survival of Patients with Breast Cancer: Evidence Based on Health Care Data from the WiZen Study

Impact of breast cancer subtypes and patterns of metastasis on outcome

Changes in classification of genetic variants in BRCA1 and BRCA2

Intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for neoadjuvant treatment of high-risk early breast cancer (GeparOcto—GBG 84): A randomised phase III trial

Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D

Prevalence of BRCA1/2 germline mutations in 21 401 families with breast and ovarian cancer

LIFESTYLE und erblicher Brustkrebs: Welche nicht-genetischen Faktoren beeinflussen das Erkrankungsrisiko?

LIFESTYLE und erblicher Brustkrebs

High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer

Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1)

Familial Breast Cancer - Targeted Therapy in Secondary and Tertiary Prevention

Suchergebnisse filtern